MYWOT
Child safety
Confidence
Trustworthiness
Confidence
MALICIOUS CONTENT INDICATORS
Eligo.bio most likely does not offer any malicious content.
Secure connection support
HTTPS
Eligo.bio provides SSL-encrypted connection.
ADULT CONTENT INDICATORS
Eligo.bio most likely does not offer any adult content.
Popular pages
-
Eligo | News & Press - Eligo Bioscience
10.2022 / Press release Eligo Bioscience Receives FDA Orphan Drug Designation (ODD) and Rare Pediatric Disease (RPD) Designation with First-in-class CRISPR-based medicine 09.2022 / Press release Eli...
-
Eligo Bioscience Raises $30 Million To Write a Novel Chapter for Genetic Medicines
In-vivo gene editing of the microbiome to solve unmet needs in immuno-inflammation, oncology and infectious diseases.
-
Eligo Bioscience Publishes Landmark Study in Nature
For the first time, a team of scientists at Eligo has demonstrated it was possible to genetically modify bacteria directly in the gut of animals.
-
Eligo presents preclinical data for lead drug candidate EB003
Paris, France - Eligo Bioscience SA (Eligo) today announced positive in-vivo data generated using their highly differentiated CRISPR-based antimicrobial platform.
-
FDA grants Eligo's CRISPR-based medicine both ODD & RPD
Eligo Receives FDA Orphan Drug Designation and Rare Pediatric Disease with First-in-class CRISPR-based medicine
-
Eligo | In vivo gene editing of the microbiome platform - Eligo Bioscience
Armed with a CRISPR system, our Eligobiotics ® become highly precise antimicrobials. They kill only the harmful bacteria by creating lethal DNA breaks in target sequences of their genome, while leavin...